Marco A. Chacón

Marco A. Chacón serves as Chairman of the Board at the Center for Breakthrough Medicines since January 2020, contributing to the company's mission of providing comprehensive solutions for the biotechnology and pharmaceutical industries. As Founder and President of IRAZÚ BIO, established in September 2019, Marco focuses on enhancing the value of intellectual property and advancing early-stage ideas through clinical trials. Previously, Marco held the position of AVP for Industry Alliances at the University of Maryland Baltimore from February 2017 to September 2019 and was the Founder, Chairman of the Board of Directors, and President & CEO of Paragon Bioservices, Inc. until February 2017, where the organization specialized in biopharmaceutical development and manufacturing. Marco holds a PhD in Nutritional Sciences from the University of Maryland.